Leaflet TRAVAPRESS 40mcg / ml ophthalmic drops solution

Product code:
W61625001
Quantity:
1
Indicated for:
glaucoma; ocular hypertension
Route of administration:
ophthalmic
Substance:
travoprost (glaucoma agent)
ATC
S01EE04 — Sensory organs | Antiglaucoma preparations and miotics | Prostaglandin analogues
Travoprost is a prostaglandin F2-alpha analog used in the treatment of open-angle glaucoma and ocular hypertension. It works by increasing the outflow of aqueous humor, thereby reducing intraocular pressure and preventing optic nerve damage.

Travoprost is administered as eye drops, usually once daily in the evening. It is indicated for patients requiring effective and long-lasting intraocular pressure reduction.

Common side effects include conjunctival hyperemia, ocular irritation, changes in iris pigmentation, and eyelash growth. In rare cases, severe adverse reactions such as macular edema or allergic reactions may occur. It is important for patients to follow their doctor's instructions and avoid excessive use.

Travoprost is an effective and well-tolerated therapeutic option for managing elevated intraocular pressure, helping to prevent vision loss and maintain ocular health.

General data about TRAVAPRESS 40mcg / ml

Substance:
travoprost
Date of latest medicines list:
01-07-2015
Product code:
W61625001
Concentration:
40mcg / ml
Pharmaceutical form:
ophthalmic drops solution
Quantity:
1
Product type:
Generic medicine
Prescription status:
P-6L — Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.

Marketing authorisation

Manufacturer:
ROMPHARM COMPANY S.R.L. - ROMANIA
Holder:
ROMPHARM COMPANY S.R.L. - ROMANIA
Number:
13807/2021/01
Shelf life:
2 years-after packing for marketing;after the first opening of the bottle-4 weeks

Concentrations available for travoprost

  • 30mcg/ml
  • 40mcg/ml

Combinations with other substances